Skip to main content
Premium Trial:

Request an Annual Quote

VT Researchers Win $100K Nvidia Award to Create Cancer Mutation Identification Platform


Two researchers from Virginia Tech have won an award from the Nvidia Foundation to create a genome analysis platform that will make it easier for researchers to identify cancer mutations.

The researchers, Wu Feng and David Mittelman, will use GPU-accelerated alignment and mapping software in combination with sensitive mutation detection methods to deliver "an optimized and powerful solution" for cancer genome analysis that other investigators can build upon.

Nvidia gave the award as part of its "Compute the Cure" program, a pilot effort overseen by its philanthropic arm, the Nvidia Foundation, that aims to leverage GPUs to support cancer researchers in the search for a cure, as well as to promote cancer awareness and prevention initiatives.

Feng, an associate professor in VT's Computer Science department, said in a statement that the program aims to "revolutionize" the way that cancer research is done by providing "a framework and toolkit of personal desktop supercomputing solutions for the analysis of genome changes from next-generation sequencing data, as a first step toward seeking a cure for cancer.”

Separately, Feng is also part of a research team funded by the National Science Foundation to develop tools for Microsoft's Azure cloud as part of an agreement between NSF and Microsoft.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.